메뉴 건너뛰기




Volumn 282, Issue 3, 1997, Pages 1242-1246

Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; MORPHINE SULFATE; NARCOTIC ANALGESIC AGENT; PREGABALIN; UNCLASSIFIED DRUG;

EID: 0030886662     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (255)

References (19)
  • 2
    • 0029942939 scopus 로고    scopus 로고
    • Characterisation of a rat model of incisional pain
    • BRENNAN, T. J., VANDERMEULEN, E. P. AND GEBHART, G. F.: Characterisation of a rat model of incisional pain. Pain 64: 493-501, 1996.
    • (1996) Pain , vol.64 , pp. 493-501
    • Brennan, T.J.1    Vandermeulen, E.P.2    Gebhart, G.F.3
  • 3
    • 0027477465 scopus 로고
    • Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence
    • CODERRE, T. J., KATZ, J., VACCARINO, A. L. AND MELZACK, R.: Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52: 259-285, 1993.
    • (1993) Pain , vol.52 , pp. 259-285
    • Coderre, T.J.1    Katz, J.2    Vaccarino, A.L.3    Melzack, R.4
  • 4
    • 0030796031 scopus 로고    scopus 로고
    • Gabapentin (Neurontin®) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents
    • in press
    • FIELD, M. J., OLES, R. J., LEWIS, A. S., MCCLEARY, S., HUGHES, J. AND SINGH, L.: Gabapentin (Neurontin®) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br. J. Pharmacol., in press, 1997.
    • (1997) Br. J. Pharmacol.
    • Field, M.J.1    Oles, R.J.2    Lewis, A.S.3    Mccleary, S.4    Hughes, J.5    Singh, L.6
  • 6
    • 0027454448 scopus 로고
    • Gabapentin: A review of its pharmacological properties and clinical potential in epilepsy
    • GOA, K. L. AND SORKIN, E. M.: Gabapentin: A review of its pharmacological properties and clinical potential in epilepsy. Drug Eval. 46: 409-427, 1993.
    • (1993) Drug Eval. , vol.46 , pp. 409-427
    • Goa, K.L.1    Sorkin, E.M.2
  • 7
    • 0023924046 scopus 로고
    • A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
    • HARGREAVES, K., DUBNER, R., BROWN, F., FLORES, C. AND JORIS, J.: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88, 1988.
    • (1988) Pain , vol.32 , pp. 77-88
    • Hargreaves, K.1    Dubner, R.2    Brown, F.3    Flores, C.4    Joris, J.5
  • 8
    • 0030990037 scopus 로고    scopus 로고
    • Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic model in the rat
    • in press
    • HWANG, J. H. AND YAKSH, T. L.: Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic model in the rat. Reg. Anaesth., in press, 1997.
    • (1997) Reg. Anaesth.
    • Hwang, J.H.1    Yaksh, T.L.2
  • 9
    • 0028365663 scopus 로고
    • Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats
    • LEE, S. H., DESMEULES, J. AND GUILBAUD, G.: Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats. Pain 57: 233-240, 1994.
    • (1994) Pain , vol.57 , pp. 233-240
    • Lee, S.H.1    Desmeules, J.2    Guilbaud, G.3
  • 10
    • 0028999227 scopus 로고
    • Gabapentin in the management of reflex sympathetic dystrophy
    • MELLICK, G. A., MELLICY, L. B. AND MELLICK, L. B.: Gabapentin in the management of reflex sympathetic dystrophy. J. Pain Symptom Manage. 10: 265-266, 1995.
    • (1995) J. Pain Symptom Manage. , vol.10 , pp. 265-266
    • Mellick, G.A.1    Mellicy, L.B.2    Mellick, L.B.3
  • 11
    • 0029993650 scopus 로고    scopus 로고
    • Gabapentin adjunctive therapy in neuropathic pain states
    • ROSNER, H., RUBIN, L. AND KESTENBAUM, A.: Gabapentin adjunctive therapy in neuropathic pain states. Clin. J. Pain 12: 56-58, 1996.
    • (1996) Clin. J. Pain , vol.12 , pp. 56-58
    • Rosner, H.1    Rubin, L.2    Kestenbaum, A.3
  • 12
    • 0029795902 scopus 로고    scopus 로고
    • The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine
    • SINGH, L., FIELD, M. J., FERRIS, P., HUNTER, J. C., OLES, R. J., WILLIAMS, R. G. AND WOODRUFF, G. N.: The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology 127: 1-9, 1996.
    • (1996) Psychopharmacology , vol.127 , pp. 1-9
    • Singh, L.1    Field, M.J.2    Ferris, P.3    Hunter, J.C.4    Oles, R.J.5    Williams, R.G.6    Woodruff, G.N.7
  • 13
    • 0030936903 scopus 로고    scopus 로고
    • Gabapentin (Neurontin®), ineffective in normal animals, markedly reduces C-fibre evoked responses after inflammation
    • STANFA, L. C., SINGH, L., WILLIAMS, R. G. AND DICKENSON, A. H.: Gabapentin (Neurontin®), ineffective in normal animals, markedly reduces C-fibre evoked responses after inflammation. NeuroReport 8: 587-590, 1997.
    • (1997) NeuroReport , vol.8 , pp. 587-590
    • Stanfa, L.C.1    Singh, L.2    Williams, R.G.3    Dickenson, A.H.4
  • 15
    • 0027458479 scopus 로고
    • Potent and stereospecific anticonvulsant activity of 3-isobutyl GABa relates to in vitro binding at a novel site labelled by tritiated gabapentin
    • TAYLOR, C. P., VARTANIAN, M. G., YUEN, P., BIGGE, C., SUMAN-CHAUHAN, N. AND HILL, D. R.: Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labelled by tritiated gabapentin. Epilepsy Res. 14: 11-15, 1993.
    • (1993) Epilepsy Res. , vol.14 , pp. 11-15
    • Taylor, C.P.1    Vartanian, M.G.2    Yuen, P.3    Bigge, C.4    Suman-Chauhan, N.5    Hill, D.R.6
  • 16
    • 0028247129 scopus 로고
    • A new strategy for the treatment of inflammatory pain: Prevention or elimination of central sensitization
    • WOOLF, C. J.: A new strategy for the treatment of inflammatory pain: prevention or elimination of central sensitization. Drugs 47: suppl. 5, 1-9, 1994.
    • (1994) Drugs , vol.47 , Issue.5 SUPPL. , pp. 1-9
    • Woolf, C.J.1
  • 17
    • 0025974775 scopus 로고
    • The induction and maintenance of cental sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states
    • WOOLF, C. J. AND THOMPSON, S. W. N.: The induction and maintenance of cental sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 44: 293-299, 1991.
    • (1991) Pain , vol.44 , pp. 293-299
    • Woolf, C.J.1    Thompson, S.W.N.2
  • 18
    • 0000596684 scopus 로고    scopus 로고
    • Gabapentin relieves abnormal pains in a rat model of painful peripheral neuropathy
    • XIAO, W. AND BENNETT, G. I.: Gabapentin relieves abnormal pains in a rat model of painful peripheral neuropathy. Soc. Neurosci. Abstr. 21: 356-1995.
    • Soc. Neurosci. Abstr. , vol.21 , pp. 356-1995
    • Xiao, W.1    Bennett, G.I.2
  • 19
    • 0024602581 scopus 로고
    • Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: Effects of modulatory receptor systems and excitatory amino acid antagonists
    • YAKSH, T. L.: Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 37: 111-123, 1989.
    • (1989) Pain , vol.37 , pp. 111-123
    • Yaksh, T.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.